Cargando…

Identification of glycogene signature as a tool to predict the clinical outcome and immunotherapy response in breast cancer

BACKGROUND: Breast cancer is one of the most important diseases in women around the world. Glycosylation modification correlates with carcinogenesis and roles of glycogenes in the clinical outcome and immune microenvironment of breast cancer are unclear. METHODS: A total of 1297 breast cancer and no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shuai, Tan, Zengqi, Cui, Hanxiao, Ma, Qilong, Zhao, Xuyan, Wu, Jianhua, Dai, Luyao, Kang, Huafeng, Guan, Feng, Dai, Zhijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515430/ https://www.ncbi.nlm.nih.gov/pubmed/36185271 http://dx.doi.org/10.3389/fonc.2022.854284

Ejemplares similares

Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer
por: Cui, Hanxiao, et al.
Publicado: (2023)

Nomogram Predicts the Role of Primary Tumor Surgery on De Novo Stage-IV Breast Cancer Patients: A SEER-Based Competing Risk Analysis Model
por: Cui, Hanxiao, et al.
Publicado: (2022)

Prognostic effect of radiotherapy in breast cancer patients underwent immediate reconstruction after mastectomy
por: Dai, Luyao, et al.
Publicado: (2022)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
por: Li, Yixi, et al.
Publicado: (2021)

Vesicular Ganglioside GM1 From Breast Tumor Cells Stimulated Epithelial-to-Mesenchymal Transition of Recipient MCF-10A Cells
por: Ma, Qilong, et al.
Publicado: (2022)

A Novel Glycolysis and Hypoxia Combined Gene Signature Predicts the Prognosis and Affects Immune Infiltration of Patients with Colon Cancer
por: Mao, Guochao, et al.
Publicado: (2022)

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
por: Wang, Luyao, et al.
Publicado: (2022)

Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival
por: Zhang, Dai, et al.
Publicado: (2021)

Identification of a six-gene signature to predict survival and immunotherapy effectiveness of gastric cancer
por: Wang, Qi, et al.
Publicado: (2023)

Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer
por: Ren, Xueting, et al.
Publicado: (2022)

The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer
por: Dai, Luyao, et al.
Publicado: (2022)

Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes
por: Wang, Yue, et al.
Publicado: (2023)

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis
por: Li, Xiushen, et al.
Publicado: (2023)

Glycogene Expression Profiling of Hepatic Cells by RNA-Seq Analysis for Glyco-Biomarker Identification
por: Angata, Kiyohiko, et al.
Publicado: (2020)

Role of Glycans in Cancer Cells Undergoing Epithelial–Mesenchymal Transition
por: Li, Xiang, et al.
Publicado: (2016)

Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy
por: Yao, Chenjiao, et al.
Publicado: (2022)

Alteration of N-glycans and Expression of Their Related Glycogenes in the Epithelial-Mesenchymal Transition of HCV29 Bladder Epithelial Cells
por: Guo, Jia, et al.
Publicado: (2014)

Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients
por: Zhang, Dai, et al.
Publicado: (2021)

Perspectives on Immunotherapy of Metastatic Colorectal Cancer
por: Dai, Yongjiu, et al.
Publicado: (2021)

Identification of a 12-Gene Signature and Hub Genes Involved in Kidney Wilms Tumor via Integrated Bioinformatics Analysis
por: Huang, Guoping, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy
por: Ma, Jianli, et al.
Publicado: (2022)

Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling
por: Cheng, Lanming, et al.
Publicado: (2020)

Identification of Subtype-Specific Metastasis-Related Genetic Signatures in Sarcoma
por: Li, Ya-Ling, et al.
Publicado: (2020)

Identification and Validation of a Prognostic Signature for Prostate Cancer Based on Ferroptosis-Related Genes
por: Liu, Huan, et al.
Publicado: (2021)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Identification of Five Glycolysis-Related Gene Signature and Risk Score Model for Colorectal Cancer
por: Zhu, Jun, et al.
Publicado: (2021)

Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients
por: Wang, Yangyang, et al.
Publicado: (2021)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
por: Wang, Weijia, et al.
Publicado: (2021)

Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma
por: Qi, Xiaoguang, et al.
Publicado: (2020)

Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation
por: Khan, Tashbib, et al.
Publicado: (2020)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
por: Nie, Ye, et al.
Publicado: (2021)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma
por: Liu, Hongxiang, et al.
Publicado: (2023)

Identification of a Five-Pseudogene Signature for Predicting Survival and Its ceRNA Network in Glioma
por: Wang, Yulin, et al.
Publicado: (2019)

Identification of SPP1 as an Extracellular Matrix Signature for Metastatic Castration-Resistant Prostate Cancer
por: Pang, Xiaocong, et al.
Publicado: (2019)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma
por: Fang, Lishan, et al.
Publicado: (2023)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma
por: Xu, Chaojie, et al.
Publicado: (2022)

When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies
por: Dai, Xiaofeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6idjcap9n10rgpg06dcosr2uha